Bionano Genomics(BNGO) - 2024 Q2 - Quarterly Results

Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress • Q2 2024 revenue was $7.8 million, which represents a 10% decrease from Q2 2023 • Total installed base of 363 optical genome mapping (OGM) systems as of Q2 2024, which represents a 29% increase over Q2 2023 • Sold 6,165 nanochannel array flowcells in Q2 2024, which represents a 13% decrease from the number of flowcells sold in Q2 2023 th • The editorial panel of the American Medical Association (AMA) established a new Categ ...